🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

EeeLN H. Buckarma

Mayo Clinic in Arizona

ORCID: 0000-0002-6396-3176

Also affiliated with Mayo Clinic in Florida

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma”.

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma

Journal of Clinical Investigation(2020)10.1172/jci137110
N/A
0DataRank · unranked
399 citations

Jingchun Yang, EeeLN H. Buckarma, Juan Wang, Yuanhang Liu, Caitlin B. Conboy +9 more

Preclinical evaluation of LCK as a novel therapeutic target in YAP-activated and FGFR2-altered cholangiocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.463
N/A
0DataRank · unranked
1 citations

Jennifer A. Yonkus, EeeLN H. Buckarma, Dong‐Gi Mun, Nathan W. Werneburg, Ryan Watkins +13 more

A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis

PNAS Nexus(2024)10.1093/pnasnexus/pgae096
N/A
0DataRank · unranked
4 citations

Ana M. Gamo, Seung Hyuk Choi, Manoj Kumar, EeeLN H. Buckarma, Chantal E. McCabe +25 more

The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes

Cellular Oncology(2025)10.1007/s13402-025-01133-x
N/A
0DataRank · unranked
0 citations

Jayla T. Millender, Chantal E. McCabe, Ryan D. Watkins, Jennifer A. Yonkus, EeeLN H. Buckarma +7 more